Progression of asymptomatic mild carotid artery stenosis: Implications for frequency of surveillance

Vasc Med. 2017 Oct;22(5):411-417. doi: 10.1177/1358863X17722215. Epub 2017 Aug 19.

Abstract

We looked retrospectively at the 3- to 5-year progression of mild, asymptomatic carotid artery stenosis (CAS). A random sample of 600 patients who had undergone at least two carotid artery duplex ultrasounds between 31 October 2006 and 1 November 2016 with a second duplex ⩾3 and ⩽5 years following the initial one were screened for inclusion. Internal carotid arteries (ICAs) were included if they had 20-49% stenosis on the initial duplex, with 440 carotid arteries meeting this criteria. Analyses were performed utilizing chi-squared and two-tailed t-tests. Twenty-four (5.45%) of the initial 440 carotid arteries progressed to moderate CAS. There was a statistically significant increase in the prevalence of hypertension (68% vs 47%, p=0.022) and diabetes mellitus (44% vs 22%, p=0.008) in patients with carotids that progressed to moderate CAS. There was a decrease in moderate-intensity statin use (32% vs 58%, p=0.005) and an increase in patients not on statins (36% vs 11%, p=0.001) in the group of carotids that progressed to moderate CAS. One carotid artery (0.2%) progressed from mild CAS to severe CAS. If supported by others, our data may lead to a change in the recommendations regarding appropriate follow-up of asymptomatic CAS.

Keywords: CAS progression; carotid artery disease; carotid artery stenosis (CAS); carotid duplex ultrasound; optimal medical therapy; statins.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carotid Arteries / diagnostic imaging*
  • Carotid Stenosis / diagnostic imaging*
  • Carotid Stenosis / epidemiology
  • Chi-Square Distribution
  • Comorbidity
  • Diabetes Mellitus / epidemiology
  • Disease Progression
  • Dyslipidemias / drug therapy
  • Dyslipidemias / epidemiology
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertension / epidemiology
  • Iowa / epidemiology
  • Male
  • Predictive Value of Tests
  • Prevalence
  • Prognosis
  • Protective Factors
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Ultrasonography, Doppler, Duplex*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors